Skip Navigation

Wilmer Research

The Johns Hopkins Wilmer Eye Institute is the largest department of ophthalmology in the United States and is an internationally-recognized research enterprise. Wilmer receives more funding from the National Eye Institute than any other university system, and is a leading recipient of research funding in the nation.
Wilmer is a thriving place for basic, clinical and translational research. Our researchers are thought leaders in the realm of discovery, dedicated to alleviating human suffering from eye disease by transforming ophthalmic care through innovative research. Our collaboration with multidisciplinary, world-renowned experts in fields such as gene therapy, nanotechnology, and stem cell research, have resulted in groundbreaking discoveries and therapies that enable us to change the way the world sees.

Our Research Teams

researchers huddle around tool

The Center for Nanomedicine

A unique translational nanotechnology enterprise that brings engineers, scientists and clinicians together as one on the translation of novel drug and gene delivery technologies.

retina cells in dish


The Center for Stem Cells and Ocular Regenerative Medicine (STORM) is a pioneering, collaborative research effort across Johns Hopkins to study and cure vision loss and blindness through regenerative medicine.

A sample of cell matter observed on microscope

Wilmer Core Research Centers

In support of creating a highly collaborative, interdisciplinary research environment, Wilmer has several research resource centers known as the Wilmer Core.

microscopic image of the eye's cornea

Cornea, Cataract & External Disease

Aimed at improving the diagnosis, management and treatment of corneal and external disease problems, including cataracts, corneal transplantation, dry eye, contact lenses and excimer laser therapy.

Dr. Sheila West in Africa with local residents

Dana Center for Preventive Ophtalmology

Focuses on national and international public health prevention of blinding eye disease. Major studies include: diabetic retinopathy, trachoma, glaucoma, and vision loss and function.

doctor in surgery observing through machine


The vision for the Glaucoma division is to dramatically improve the outcome for those affected by glaucoma worldwide through groundbreaking diagnostic and therapeutic methods.

Microscopic image of optical nerve cells


Aims to advance the prevention and treatment of neuro-ophthalmic disorders through groundbreaking research.


Ocular Immunology

Focused on the causes and treatments of ocular inflammatory diseases, including uveitis, intraocular inflammation, scleritis and iritis.

microscopic image of eye tissue


The Ocular Vasculogenesis and Angiogenesis Laboratory (OVAL) studies the development of blood vessels in the eye and how they change in diseases of the eye.

A patient lies down with head covered for surgery


Currently engaged in research focused on structures around the eyes and their relation to ocular diseases and orbital trauma, and their treatments.

eye doctor performing fun optical test with child

Pediatric Ophthalmology & Adult Stabismus

Focuses on detection, management and treatment of pediatric and adult strabismus and amblyopia, as well as clinical technology development and investigative clinical trials.

dr. mira sachdeva looks at computer with lab tech


Includes projects and multiple laboratories engaged in groundbreaking discoveries aimed at transforming the study and treatment of retinal diseases.

researcher in the lab with cell samples


Translational Tissue Engineering Center (TTEC) is a joint venture of Wilmer and the Department of Biomedical Engineering to establish a focus in research, education, and industrial development in regenerative medicine.

older man recieving eye exam

Ultra Low Vision

Focused on assessing and enhancing the functional visual abilities of individuals with ultra-low vision.

back to top button